Whole-exome sequencing of 228 patients with sporadic Parkinson’s disease

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[3]  M. Scully,et al.  Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies , 2019, British journal of haematology.

[4]  H. Woodrow,et al.  : A Review of the , 2018 .

[5]  Brahmanpally Balkishan,et al.  A Clinicopathological Study of 100 Cases of Cervical Lymphadenopathy , 2016 .

[6]  Andrew B Singleton,et al.  Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance , 2016, Journal of neurochemistry.

[7]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[8]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2015, Nature.

[9]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[10]  Y. Ben-Shlomo,et al.  Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort , 2015, Journal of Parkinson's disease.

[11]  S. Robertson,et al.  Congenital mirror movements: Phenotypes associated with DCC and RAD51 mutations , 2015, Journal of the Neurological Sciences.

[12]  C. van Broeckhoven,et al.  Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. , 2015, Trends in genetics : TIG.

[13]  Y. Ben-Shlomo,et al.  Letter in response to Picillo et al., in relation to Szewczyk-Krolikowski et al.: the influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson disease Center (OPDC) discovery cohort. , 2014, Parkinsonism & related disorders.

[14]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[15]  Nicolas Alexandre,et al.  RAD51 deficiency disrupts the corticospinal lateralization of motor control. , 2013, Brain : a journal of neurology.

[16]  Ran An,et al.  Association Studies of MMP-9 in Parkinson’s Disease and Amyotrophic Lateral Sclerosis , 2013, PloS one.

[17]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[18]  Eng-King Tan,et al.  Whole-genome and whole-exome sequencing in neurological diseases , 2012, Nature Reviews Neurology.

[19]  Adam Kiezun,et al.  Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.

[20]  M. Cincotta,et al.  Mirror Movements in Movement Disorders: A Review , 2012, Tremor and other hyperkinetic movements.

[21]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[22]  Yurii S. Aulchenko,et al.  The Empirical Power of Rare Variant Association Methods: Results from Sanger Sequencing in 1,998 Individuals , 2012, PLoS genetics.

[23]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[24]  N. Pedersen,et al.  Heritability of Parkinson disease in Swedish twins: a longitudinal study , 2011, Neurobiology of Aging.

[25]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[26]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[27]  H. Adami,et al.  Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.

[28]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[29]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[30]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[31]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[32]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[33]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[34]  S. Lorenzl,et al.  Expression of MMP-2, MMP-9, and MMP-1 and Their Endogenous Counterregulators TIMP-1 and TIMP-2 in Postmortem Brain Tissue of Parkinson's Disease , 2002, Experimental Neurology.

[35]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[36]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[37]  R. Snow,et al.  Review of the Evidence. , 1964, Science.

[38]  Y. Ben-Shlomo,et al.  The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. , 2014, Parkinsonism & Related Disorders.

[39]  Maja O’Connor,et al.  A Longitudinal Study , 2013 .

[40]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[41]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .